Skip to main content

Table 1 Parameters before TAA surgery (baseline) in each group analysed (mean ± SD)

From: Fibrinogen concentrate administration attributes to significant reductions of blood loss and transfusion requirements in thoracic aneurysm repair

 

Only FFP (n = 24)

Fibrinogen concentrate (n = 25)

Hb (g/dL)

13.7 ± 2.7

14.2 ± 2.9

Platelet (× 1000/μL)

178 ± 57

153 ± 38

PT (sec.)

11.2 ± 1.3

11.4 ± 1.0

APTT (sec.)

33.7 ± 2.6

34.1 ± 2.8

Fibrinogen (mg/dL)

Baseline

275 ± 66

268 ± 57

End of CPB

116 ± 33

108 ± 39

End of operation

141 ± 36

252 ± 46*

  1. The fibrinogen levels at the end of CPB and of surgery in each group are also indicated.
  2. TAA: thoracic aortic aneurysm; CPB: cardiopulmonary bypass; Hb: hemoglobin; PT: prothrombin time; APTT: activated partial thromboplastin time; *P < 0.02.